Botulinum Development

Foreign Biowarfare Development

Japanese Experiments on Prisoners

1935

Biological and Toxin Weapons Convention

1972

Iraqi Biowarfare Program

1985 - 1991

Japan: First Terrorist Use

1990

Japan: Second Terrorist Use

1995

US Defense Development

WWII: US Produces 100M Vaccines

1944

Canada: First Commercial Antitoxin

1964

US Botulinum Therapy Project

1975 - 2013

HBAT Deployed in Egypt

1991

Antitoxin Production Licensed to Cangene

2006

HBAT FDA Approval

2013